Pages that link to "Q34722632"
Jump to navigation
Jump to search
The following pages link to Structure-activity relationships for inhibition of cysteine protease activity and development of Plasmodium falciparum by peptidyl vinyl sulfones (Q34722632):
Displaying 50 items.
- Vinyl Sulfones as Antiparasitic Agents and a Structural Basis for Drug Design (Q27646557) (← links)
- Mining a cathepsin inhibitor library for new antiparasitic drug leads (Q28478016) (← links)
- Blocking Plasmodium falciparum development via dual inhibition of hemoglobin degradation and the ubiquitin proteasome system by MG132 (Q28536452) (← links)
- Insights into the Interactions of Fasciola hepatica Cathepsin L3 with a Substrate and Potential Novel Inhibitors through In Silico Approaches (Q28547256) (← links)
- Structural basis for unique mechanisms of folding and hemoglobin binding by a malarial protease (Q28914748) (← links)
- Chemical genetics of Plasmodium falciparum (Q29617272) (← links)
- Characterization of the Plasmodium falciparum M17 leucyl aminopeptidase. A protease involved in amino acid regulation with potential for antimalarial drug development (Q30043603) (← links)
- Antimalarial activity of azadipeptide nitriles (Q33637348) (← links)
- Identification of Novel Malarial Cysteine Protease Inhibitors Using Structure-Based Virtual Screening of a Focused Cysteine Protease Inhibitor Library (Q33853116) (← links)
- The Plasmodium falciparum cysteine protease falcipain-2 captures its substrate, hemoglobin, via a unique motif (Q33878982) (← links)
- Plasmodium falciparum cysteine protease falcipain-1 is not essential in erythrocytic stage malaria parasites (Q34514862) (← links)
- Enone– and Chalcone–Chloroquinoline Hybrid Analogues: In Silico Guided Design, Synthesis, Antiplasmodial Activity, in Vitro Metabolism, and Mechanistic Studies (Q35014243) (← links)
- Novel anti-plasmodial hits identified by virtual screening of the ZINC database (Q35026098) (← links)
- Synthetic compounds from an in house library as inhibitors of falcipain-2 from Plasmodium falciparum (Q35194816) (← links)
- Antimalarial drug discovery: old and new approaches (Q35541777) (← links)
- Inhibition of Plasmodium falciparum oocyst production by membrane-permeant cysteine protease inhibitor E64d (Q35647780) (← links)
- 6. Cathepsin K inhibitors: their potential as anti-osteoporosis agents (Q35683586) (← links)
- Antimalarial drug discovery: efficacy models for compound screening (Q35790381) (← links)
- How to control NO production in cells: N(omega),N(omega)-dimethyl-L-arginine dimethylaminohydrolase as a novel drug target (Q36471209) (← links)
- Synthesis and Evaluation of Oxyguanidine Analogues of the Cysteine Protease Inhibitor WRR-483 against Cruzain (Q36473159) (← links)
- Ferrous iron-dependent delivery of therapeutic agents to the malaria parasite (Q36616566) (← links)
- Synthesis of macrocyclic trypanosomal cysteine protease inhibitors (Q37097725) (← links)
- Artemisinin-dipeptidyl vinyl sulfone hybrid molecules: design, synthesis and preliminary SAR for antiplasmodial activity and falcipain-2 inhibition (Q37343543) (← links)
- The proteasome inhibitor epoxomicin has potent Plasmodium falciparum gametocytocidal activity (Q37392803) (← links)
- Imidazoquines as antimalarial and antipneumocystis agents (Q37459170) (← links)
- Falcipains and Other Cysteine Proteases of Malaria Parasites (Q37887586) (← links)
- Falcipain inhibitors as potential therapeutics for resistant strains of malaria: a patent review. (Q38066268) (← links)
- From crystal to compound: structure-based antimalarial drug discovery (Q38227796) (← links)
- Design, Synthesis, and Biological Evaluation of Peptidomimetic N-Substituted Cbz-4-Hyp-Hpa-Amides as Novel Inhibitors of Plasmodium falciparum (Q39215179) (← links)
- Molecular docking and 3D-quantitative structure activity relationship analyses of peptidyl vinyl sulfones: Plasmodium Falciparum cysteine proteases inhibitors. (Q39725235) (← links)
- 2-(3,4-dihydro-4-oxothieno[2,3-d]pyrimidin-2-ylthio) acetamides as a new class of falcipain-2 inhibitors. 3. design, synthesis and biological evaluation (Q40001873) (← links)
- BDA-410: a novel synthetic calpain inhibitor active against blood stage malaria (Q41438679) (← links)
- Falcipain-1, a Plasmodium falciparum cysteine protease with vaccine potential (Q41826054) (← links)
- An endoperoxide-based hybrid approach to deliver falcipain inhibitors inside malaria parasites (Q41925015) (← links)
- Antimalarial activity of thiosemicarbazones and purine derived nitriles. (Q41938383) (← links)
- Identification and biochemical characterization of vivapains, cysteine proteases of the malaria parasite Plasmodium vivax (Q42156927) (← links)
- Nonpeptidic vinyl and allyl phosphonates as falcipain-2 inhibitors (Q42167513) (← links)
- Synthesis and molecular modeling studies of derivatives of a highly potent peptidomimetic vinyl ester as falcipain-2 inhibitors. (Q42717133) (← links)
- Substrate mapping and inhibitor profiling of falcipain-2, falcipain-3 and berghepain-2: implications for peptidase anti-malarial drug discovery (Q43245922) (← links)
- Design, synthesis, conformational and molecular docking study of some novel acyl hydrazone based molecular hybrids as antimalarial and antimicrobial agents (Q44169873) (← links)
- Exploring of drug leads from diversity-oriented Michael-acceptor library derived from natural products (Q46096405) (← links)
- 2-amido-3-(1H-indol-3-yl)-N-substituted-propanamides as a new class of falcipain-2 inhibitors. 1. Design, synthesis, biological evaluation and binding model studies. (Q46153985) (← links)
- Cysteine protease falcipain 1 in Plasmodium falciparum is biochemically distinct from its isozymes (Q46616785) (← links)
- Effect of phenyl vinyl sulphone cysteine protease inhibitor on Schistosoma mansoni: in vitro and in vivo experimental studies (Q46889462) (← links)
- Structural features of falcipain-3 inhibitors: an in silico study (Q47629095) (← links)
- Synthesis and antimalarial activity of novel chiral and achiral benzenesulfonamides bearing 1, 3, 4-oxadiazole moieties (Q47839530) (← links)
- Synthesis and Evaluation of Thiochroman-4-One Derivatives as Potential Leishmanicidal Agents (Q48217630) (← links)
- Identification of cysteine protease inhibitors as new drug leads against Naegleria fowleri. (Q52650006) (← links)
- Cysteine protease inhibitors as potential antiparasitic agents (Q58423121) (← links)
- Kinetic template-guided tethering of fragments (Q87406316) (← links)